Who owns the IP
The organizations most actively patenting around this compound, ranked by referenced patent volume.
| # | Assignee | Patents |
|---|---|---|
| 1 | Taiwan Semiconductor Manufacturing Co TSMC Ltd | 6,668 |
| 2 | International Business Machines Corp | 2,518 |
| 3 | Samsung Display Co Ltd | 1,265 |
| 4 | Micron Technology Inc | 1,236 |
| 5 | GlobalFoundries US Inc | 1,063 |
| 6 | Ningde Amperex Technology Ltd | 1,054 |
| 7 | General Electric Co | 929 |
| 8 | Semiconductor Energy Laboratory Co Ltd | 915 |
| 9 | Intel Corp | 895 |
| 10 | Samsung Electronics Co Ltd | 862 |
Explore the full landscape
This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.
Visit CyprisWhere innovation is concentrated
Patent classifications ranked by volume reveal the technical domains with the most active filing.
| # | Code | Area | Patents |
|---|---|---|---|
| 1 | H01L | Semiconductor devices | 28,050 |
| 2 | H10D | 27,322 | |
| 3 | H10P | 14,993 | |
| 4 | H10W | 10,386 | |
| 5 | H10B | 9,679 |
| 6 | Y02E | Climate change mitigation: energy | 6,945 |
| 7 | C23C | 6,637 | |
| 8 | B82Y | Nanotechnology | 5,304 |
| 9 | C04B | 5,040 | |
| 10 | H10K | Organic semiconductors / OLEDs | 4,800 |
AI mapped opportunity space
This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.
See Cypris in actionMost-cited patents
Patents ranked by forward citations reveal the foundational inventions the field continues to build on.
| Title | Year | Assignee | Cited by |
|---|---|---|---|
| Lanthanum hafnium oxide dielectrics | 2007 | Micron Technology Inc | 592 |
| Lanthanide oxide / hafnium oxide dielectric layers | 2007 | Micron Technology Inc | 579 |
| Lanthanide oxide / hafnium oxide dielectric layers | 2007 | Micron Technology Inc | 555 |
| Lanthanide oxide / hafnium oxide dielectrics | 2006 | Micron Technology Inc | 107 |
| Deposition of hafnium oxide and/or zirconium oxide and fabrication of passivated electronic structures | 2006 | GlobalFoundries Inc | 100 |
Where research is gaining momentum
Research themes ranked by publication activity show where scientific interest is accelerating around this compound.
| # | Research topic | Papers |
|---|---|---|
| 1 | interferon and immune responses | 1 |
Who's driving the science
The most-published authors working with this compound, alongside their primary affiliations.
| # | Author | Affiliation | Papers |
|---|---|---|---|
| 1 | Julie Marill | Nanobiotix (France) | 4 |
| 2 | Naeemunnisa Mohamed Anesary | Nanobiotix (France) | 4 |
| 3 | C. Le Péchoux | Institut Gustave Roussy | 3 |
| 4 | Elsa Borghi | Nanobiotix (France) | 3 |
| 5 | Juliette Thariat | Centre François Baclesse | 3 |
| 6 | Laurent Lévy | Nanobiotix (France) | 3 |
| 7 | Sébastien Paris | Nanobiotix (France) | 3 |
| 8 | Agnès Pottier | Nanobiotix (France) | 2 |
| 9 | Audrey Darmon | Nanobiotix (France) | 2 |
| 10 | Blassan P. George | University of Johannesburg | 1 |
Research leaders
This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.
See Cypris in actionThe literature that defines it
The most-cited papers anchoring the scientific record for this compound.
| Title | Year | Cited by | Topic |
|---|---|---|---|
| NBTXR3, a first-in-class radioenhancer hafnium oxide nanoparticle, plus radiotherapy versus radiotherapy alone in patients with locally advanced soft-tissue sarcoma (Act.In.Sarc): a multicentre, phase 2–3, randomised, controlled trial | 2019 | 518 | Sarcoma Diagnosis and Treatment |
| Nanoscale Radiotherapy with Hafnium Oxide Nanoparticles | 2012 | 366 | Advanced Radiotherapy Techniques |
| High-Bandwidth Protein Analysis Using Solid-State Nanopores | 2014 | 256 | Microfluidic and Bio-sensing Technologies |
| First-in-Human Study Testing a New Radioenhancer Using Nanoparticles (NBTXR3) Activated by Radiation Therapy in Patients with Locally Advanced Soft Tissue Sarcomas | 2016 | 239 | Sarcoma Diagnosis and Treatment |
| RRAM-based synapse devices for neuromorphic systems | 2018 | 232 | Advanced Memory and Neural Computing |
Frequently asked questions
Common questions about this compound's patent and research landscape, answered from the underlying data.
What is the molecular formula and weight of hafnium dioxide?
Which organizations hold the most patents related to hafnium dioxide?
What are the primary technology areas covered by hafnium dioxide patents?
What medical applications of hafnium oxide nanoparticles are documented in recent research?
What is the recent patent activity trend for hafnium dioxide?